Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronny Drapkin

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2026
Efficient in vivo assembly of DNA encoded multivalent BTEs for dual antigen targeting for broadening therapeutic impact in ovarian cancerPratik S Bhojnagarwala, Devivasha Bordoloi, Joshua S Jose, et al.
Scientific Reports|November 22, 2018
Expression of the POTE gene family in human ovarian cancerCarter J Barger, Wa Zhang, Ashok Sharma, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer developmentRobbin A Nameki, Heidi Chang, Pak Yu, et al.
Neoplasia (New York, N.Y.)|February 4, 2010
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survivalAdam Clauss, Vivian Ng, Joyce Liu, et al.
Science Translational Medicine|March 11, 2016
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironmentSuming Wang, Anna Blois, Tina El Rayes, et al.
The American Journal of Surgical Pathology|May 10, 2011
A comprehensive analysis of PAX8 expression in human epithelial tumorsAnna R Laury, Ruth Perets, Huiying Piao, et al.
Nature Communications|June 3, 2024
Dormant origin firing promotes head-on transcription-replication conflicts at transcription termination sites in response to BRCA2 deficiencyLiana Goehring, Sarah Keegan, Sudipta Lahiri, et al.
Nature Communications|August 30, 2017
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug responseIoannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, et al.
Scientific Reports|October 5, 2018
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancerBipradeb Singha, Sandra L Harper, Aaron R Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISANathalie Scholler, Kimberly A Lowe, Lindsay A Bergan, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2026
Efficient in vivo assembly of DNA encoded multivalent BTEs for dual antigen targeting for broadening therapeutic impact in ovarian cancerPratik S Bhojnagarwala, Devivasha Bordoloi, Joshua S Jose, et al.
Scientific Reports|November 22, 2018
Expression of the POTE gene family in human ovarian cancerCarter J Barger, Wa Zhang, Ashok Sharma, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer developmentRobbin A Nameki, Heidi Chang, Pak Yu, et al.
Neoplasia (New York, N.Y.)|February 4, 2010
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survivalAdam Clauss, Vivian Ng, Joyce Liu, et al.
Science Translational Medicine|March 11, 2016
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironmentSuming Wang, Anna Blois, Tina El Rayes, et al.
The American Journal of Surgical Pathology|May 10, 2011
A comprehensive analysis of PAX8 expression in human epithelial tumorsAnna R Laury, Ruth Perets, Huiying Piao, et al.
Nature Communications|June 3, 2024
Dormant origin firing promotes head-on transcription-replication conflicts at transcription termination sites in response to BRCA2 deficiencyLiana Goehring, Sarah Keegan, Sudipta Lahiri, et al.
Nature Communications|August 30, 2017
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug responseIoannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, et al.
Scientific Reports|October 5, 2018
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancerBipradeb Singha, Sandra L Harper, Aaron R Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISANathalie Scholler, Kimberly A Lowe, Lindsay A Bergan, et al.
Pageof 18